MarketCapTrends
LFCR
Lifecore Biomedical, Inc. (LFCR)
NASDAQ · Healthcare

Lifecore Biomedical, Inc. Shareholder Equity 2010–2025

Lifecore Biomedical, Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Lifecore Biomedical, Inc. shareholder equity for the quarter ending May 25, 2025 were 1.3M, a 88.19% decrease year-over-year.
  • Lifecore Biomedical, Inc. shareholder equity for 2025 were 1.3M, a 88.19% decrease from 2024.
  • Lifecore Biomedical, Inc. shareholder equity for 2024 were 11.3M, a 367.49% decrease from 2023.
  • Lifecore Biomedical, Inc. shareholder equity for 2023 were -4.2M, a 104.82% decrease from 2022.
  • Lifecore Biomedical, Inc. shareholder equity for 2022 were 87.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Lifecore Biomedical, Inc. Annual Shareholder Equity (Millions of US $)
2025$1
2024$11
2023$-4
2022$88
2021$202
2020$230
2019$270
2018$253
2017$227
2016$211
2015$218
2014$203
2013$179
2012$150
2011$136
Lifecore Biomedical, Inc. Quarterly Shareholder Equity (Millions of US $)
2025-05-25$1
2024-05-26$11
2023-05-28$-4
2022-05-29$88
2021-05-30$202
2020-05-31$230
2019-05-26$270
2018-05-27$253
2017-05-28$227
2016-05-29$211
2015-05-31$218
2014-05-25$203
2013-05-26$179
2012-05-27$150
2011-05-29$136

Lifecore Biomedical, Inc. Shareholder Equity — FAQ

Lifecore Biomedical, Inc. (LFCR) shareholder equity over the last 16 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LFCR's shareholder equity history?

The chart and table above show Lifecore Biomedical, Inc.'s shareholder equity by year and by quarter, including the growth rate.